Development of an intracranial mass‐like lesion during growth hormone treatment in a pediatric patient with history of medulloblastoma
Pediatric Blood & Cancer2020Vol. 68(2), pp. e28616–e28616
Citations Over Time
Abstract
The authors declare that there is no conflict of interest.
Related Papers
- → Suberoylanilide hydroxamic acid is effective in preclinical studies of medulloblastoma(2006)46 cited
- → PRMT1 is an important factor for medulloblastoma cell proliferation and survival(2022)7 cited
- → Pseudotumoral brain lesion as the presenting feature of sarcoidosis(1996)14 cited
- → Is adult medulloblastoma merely the counterpart of pediatric medulloblastoma?(2020)1 cited
- THE MEDICAL IMAGING & PATHOLOGICAL ANALYSIS OF MEDULLOBLASTOMA IN CHILDREN(2006)